Credit: K KStock/Adobe stock
There has been a meteoric rise in popularity of the class of drugs commonly known as GLP-1s—including name brand drugs such as Ozempic and Wegovy. In addition, some plan sponsors have experienced a staggering increase in plan costs as a result of these drugs, which can run well over $1,000 per month. Initially approved to help diabetes patients control their blood sugar, drugs such as Ozempic have soared in popularity in recent years, in large part due to their popular side effect of rapid weight loss. Social media attention and popular culture references have fueled the rising awareness.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
